Compile Data Set for Download or QSAR

Found 168 hits Enz. Inhib. hit(s) with Target = 'Malignant T-cell-amplified sequence 1'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345287 (2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclopropyl...) Show SMILES CC(C)(OCc1cc(-c2cccc(OCC3CC3)c2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C25H27ClN2O4/c1-25(2,24(29)30)32-16-20-13-23(28(27-20)14-19-6-3-4-9-22(19)26)18-7-5-8-21(12-18)31-15-17-10-11-17/h3-9,12-13,17H,10-11,14-16H2,1-2H3,(H,29,30)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	54.5	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345295 (1-[[1-[(2-Chlorophenyl)methyl]-5-(3- methoxypheny...) Show SMILES COc1cccc(c1)-c1cc(COC2(CCC2)C(O)=O)nn1Cc1ccccc1Cl Show InChI InChI=1S/C23H23ClN2O4/c1-29-19-8-4-7-16(12-19)21-13-18(15-30-23(22(27)28)10-5-11-23)25-26(21)14-17-6-2-3-9-20(17)24/h2-4,6-9,12-13H,5,10-11,14-15H2,1H3,(H,27,28)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	100	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345271 (1-[[5-(4-Chlorophenyl)-1-[(2- chlorophenyl)methyl...) Show SMILES OC(=O)C1(CC1)OCc1cc(-c2ccc(Cl)cc2)n(Cc2ccccc2Cl)n1 Show InChI InChI=1S/C21H18Cl2N2O3/c22-16-7-5-14(6-8-16)19-11-17(13-28-21(9-10-21)20(26)27)24-25(19)12-15-3-1-2-4-18(15)23/h1-8,11H,9-10,12-13H2,(H,26,27)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	100	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345291 (2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclobutoxy...) Show SMILES CC(C)(OCc1cc(-c2cccc(OC3CCC3)c2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C25H27ClN2O4/c1-25(2,24(29)30)31-16-19-14-23(28(27-19)15-18-7-3-4-12-22(18)26)17-8-5-11-21(13-17)32-20-9-6-10-20/h3-5,7-8,11-14,20H,6,9-10,15-16H2,1-2H3,(H,29,30)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	204	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345298 (2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclopentyl...) Show SMILES CC(C)(OCc1cc(-c2cccc(OCC3CCCC3)c2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C27H31ClN2O4/c1-27(2,26(31)32)34-18-22-15-25(30(29-22)16-21-10-5-6-13-24(21)28)20-11-7-12-23(14-20)33-17-19-8-3-4-9-19/h5-7,10-15,19H,3-4,8-9,16-18H2,1-2H3,(H,31,32)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	204	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345281 (2-[[1-[(2-Chlorophenyl)methyl]-5-(3- isobutoxyphe...) Show SMILES CC(C)COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl Show InChI InChI=1S/C25H29ClN2O4/c1-17(2)15-31-21-10-7-9-18(12-21)23-13-20(16-32-25(3,4)24(29)30)27-28(23)14-19-8-5-6-11-22(19)26/h5-13,17H,14-16H2,1-4H3,(H,29,30)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	302	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345334 (US10202350, Example 81 | US10214492, Example 81 | ...) Show SMILES COc1cccc(c1)-c1cc(COC(C)(C)C(=O)NS(C)(=O)=O)nn1Cc1ccccc1Cl Show InChI InChI=1S/C23H26ClN3O5S/c1-23(2,22(28)26-33(4,29)30)32-15-18-13-21(16-9-7-10-19(12-16)31-3)27(25-18)14-17-8-5-6-11-20(17)24/h5-13H,14-15H2,1-4H3,(H,26,28)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	303	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345260 (2-[[5-(4-Chlorophenyl)-1-[(2,4- dichlorophenyl)me...) Show SMILES OC(=O)COCc1cc(-c2ccc(Cl)cc2)n(Cc2ccc(Cl)cc2Cl)n1 Show InChI InChI=1S/C19H15Cl3N2O3/c20-14-4-1-12(2-5-14)18-8-16(10-27-11-19(25)26)23-24(18)9-13-3-6-15(21)7-17(13)22/h1-8H,9-11H2,(H,25,26)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	303	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345259 (2-[[5-(4-Chlorophenyl)-1-[(2,4- dichlorophenyl)me...) Show SMILES CC(C)(OCc1cc(-c2ccc(Cl)cc2)n(Cc2ccc(Cl)cc2Cl)n1)C(O)=O Show InChI InChI=1S/C21H19Cl3N2O3/c1-21(2,20(27)28)29-12-17-10-19(13-3-6-15(22)7-4-13)26(25-17)11-14-5-8-16(23)9-18(14)24/h3-10H,11-12H2,1-2H3,(H,27,28)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	400	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345264 (2-[[5-(3-Chlorophenyl)-1-[(2- chlorophenyl)methyl...) Show SMILES CC(C)(OCc1cc(-c2cccc(Cl)c2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C21H20Cl2N2O3/c1-21(2,20(26)27)28-13-17-11-19(14-7-5-8-16(22)10-14)25(24-17)12-15-6-3-4-9-18(15)23/h3-11H,12-13H2,1-2H3,(H,26,27)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	404	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345296 (2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclobutylm...) Show SMILES CC(C)(OCc1cc(-c2cccc(OCC3CCC3)c2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C26H29ClN2O4/c1-26(2,25(30)31)33-17-21-14-24(29(28-21)15-20-9-3-4-12-23(20)27)19-10-6-11-22(13-19)32-16-18-7-5-8-18/h3-4,6,9-14,18H,5,7-8,15-17H2,1-2H3,(H,30,31)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	404	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345274 (2-[[5-(4-Chlorophenyl)-1-[(2- chlorophenyl)methyl...) Show SMILES CC(C)(OCc1cc(-c2ccc(Cl)cc2)n(Cc2ccccc2Cl)n1)C(N)=O Show InChI InChI=1S/C21H21Cl2N3O2/c1-21(2,20(24)27)28-13-17-11-19(14-7-9-16(22)10-8-14)26(25-17)12-15-5-3-4-6-18(15)23/h3-11H,12-13H2,1-2H3,(H2,24,27)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	454	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345305 (US10202350, Example 51 | US10214492, Example 51 | ...) Show SMILES CC(C)c1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl Show InChI InChI=1S/C24H27ClN2O3/c1-16(2)17-9-7-10-18(12-17)22-13-20(15-30-24(3,4)23(28)29)26-27(22)14-19-8-5-6-11-21(19)25/h5-13,16H,14-15H2,1-4H3,(H,28,29)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	6.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345331 (US10202350, Example 77 | US10214492, Example 77 | ...) Show SMILES CC(C)(OCc1cc(Cc2ccccc2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C22H23ClN2O3/c1-22(2,21(26)27)28-15-18-13-19(12-16-8-4-3-5-9-16)25(24-18)14-17-10-6-7-11-20(17)23/h3-11,13H,12,14-15H2,1-2H3,(H,26,27)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	9.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345293 (2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclopropox...) Show SMILES CC(C)(OCc1cc(-c2cccc(OC3CC3)c2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C24H25ClN2O4/c1-24(2,23(28)29)30-15-18-13-22(16-7-5-8-20(12-16)31-19-10-11-19)27(26-18)14-17-6-3-4-9-21(17)25/h3-9,12-13,19H,10-11,14-15H2,1-2H3,(H,28,29)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345288 (2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (trifluorome...) Show SMILES CC(C)(OCc1cc(-c2cccc(OC(F)(F)F)c2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C22H20ClF3N2O4/c1-21(2,20(29)30)31-13-16-11-19(14-7-5-8-17(10-14)32-22(24,25)26)28(27-16)12-15-6-3-4-9-18(15)23/h3-11H,12-13H2,1-2H3,(H,29,30)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.10E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345315 (2-([1-[(2-methoxyphenyl)methyl]-5-[3-(2- methylpr...) Show SMILES COc1ccccc1Cn1nc(COC(C)(C)C(O)=O)cc1-c1cccc(OCC(C)C)c1 Show InChI InChI=1S/C26H32N2O5/c1-18(2)16-32-22-11-8-10-19(13-22)23-14-21(17-33-26(3,4)25(29)30)27-28(23)15-20-9-6-7-12-24(20)31-5/h6-14,18H,15-17H2,1-5H3,(H,29,30)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.10E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345327 (2-([1-[(2-chlorophenyl)methyl]-5-[3-[(2-methylprop...) Show SMILES CC(C)CNc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl Show InChI InChI=1S/C25H30ClN3O3/c1-17(2)14-27-20-10-7-9-18(12-20)23-13-21(16-32-25(3,4)24(30)31)28-29(23)15-19-8-5-6-11-22(19)26/h5-13,17,27H,14-16H2,1-4H3,(H,30,31)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.10E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345299 (2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (tetrahydrop...) Show SMILES CC(C)(OCc1cc(-c2cccc(OCC3CCOCC3)c2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C27H31ClN2O5/c1-27(2,26(31)32)35-18-22-15-25(30(29-22)16-21-6-3-4-9-24(21)28)20-7-5-8-23(14-20)34-17-19-10-12-33-13-11-19/h3-9,14-15,19H,10-13,16-18H2,1-2H3,(H,31,32)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.20E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345319 (US10202350, Example 65 | US10214492, Example 65 | ...) Show SMILES COc1csc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl Show InChI InChI=1S/C20H21ClN2O4S/c1-20(2,19(24)25)27-11-14-8-17(18-9-15(26-3)12-28-18)23(22-14)10-13-6-4-5-7-16(13)21/h4-9,12H,10-11H2,1-3H3,(H,24,25)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.30E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345332 (2-[[1-[(2-Chlorophenyl)methyl]-5-(3-hydroxyphenyl)...) Show SMILES CC(C)(OCc1cc(-c2cccc(O)c2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C21H21ClN2O4/c1-21(2,20(26)27)28-13-16-11-19(14-7-5-8-17(25)10-14)24(23-16)12-15-6-3-4-9-18(15)22/h3-11,25H,12-13H2,1-2H3,(H,26,27)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.50E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345282 (2-[[1-[(2-Chlorophenyl)methyl]-5-(3- ethoxyphenyl...) Show SMILES CCOc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl Show InChI InChI=1S/C23H25ClN2O4/c1-4-29-19-10-7-9-16(12-19)21-13-18(15-30-23(2,3)22(27)28)25-26(21)14-17-8-5-6-11-20(17)24/h5-13H,4,14-15H2,1-3H3,(H,27,28)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.50E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345283 (2-[[1-[(2-Bromophenyl)methyl]-5-(3- isopropoxyphe...) Show SMILES CC(C)Oc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Br Show InChI InChI=1S/C24H27BrN2O4/c1-16(2)31-20-10-7-9-17(12-20)22-13-19(15-30-24(3,4)23(28)29)26-27(22)14-18-8-5-6-11-21(18)25/h5-13,16H,14-15H2,1-4H3,(H,28,29)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.60E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345335 (Methyl 2-[[1-[(2-chlorophenyl)methyl]-5-(3-methoxy...) Show SMILES COC(=O)C(C)(C)OCc1cc(-c2cccc(OC)c2)n(Cc2ccccc2Cl)n1 Show InChI InChI=1S/C23H25ClN2O4/c1-23(2,22(27)29-4)30-15-18-13-21(16-9-7-10-19(12-16)28-3)26(25-18)14-17-8-5-6-11-20(17)24/h5-13H,14-15H2,1-4H3	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.60E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345267 (2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (trifluorome...) Show SMILES CC(C)(OCc1cc(-c2cccc(c2)C(F)(F)F)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C22H20ClF3N2O3/c1-21(2,20(29)30)31-13-17-11-19(14-7-5-8-16(10-14)22(24,25)26)28(27-17)12-15-6-3-4-9-18(15)23/h3-11H,12-13H2,1-2H3,(H,29,30)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.70E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345321 (2-([1-(o-Chlorophenyl)methyl]-5-(m-methoxyphenyl)-...) Show SMILES CCC(CC)(OCc1cc(-c2cccc(OC)c2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C24H27ClN2O4/c1-4-24(5-2,23(28)29)31-16-19-14-22(17-10-8-11-20(13-17)30-3)27(26-19)15-18-9-6-7-12-21(18)25/h6-14H,4-5,15-16H2,1-3H3,(H,28,29)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.70E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345317 (2-([1-[(4-methoxyphenyl)methyl]-5-[3-(2- methylpr...) Show SMILES COc1ccc(Cn2nc(COC(C)(C)C(O)=O)cc2-c2cccc(OCC(C)C)c2)cc1 Show InChI InChI=1S/C26H32N2O5/c1-18(2)16-32-23-8-6-7-20(13-23)24-14-21(17-33-26(3,4)25(29)30)27-28(24)15-19-9-11-22(31-5)12-10-19/h6-14,18H,15-17H2,1-5H3,(H,29,30)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.70E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345257 (2-[[5-(4-Chlorophenyl)-1-[(2- chlorophenyl)methyl...) Show SMILES CC(C)(OCc1cc(-c2ccc(Cl)cc2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C21H20Cl2N2O3/c1-21(2,20(26)27)28-13-17-11-19(14-7-9-16(22)10-8-14)25(24-17)12-15-5-3-4-6-18(15)23/h3-11H,12-13H2,1-2H3,(H,26,27)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.50E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345322 (2-([1-[(2-Chlorophenyl)methyl]-5-(3-methoxyphenyl)...) Show SMILES CCC(C)(OCc1cc(-c2cccc(OC)c2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C23H25ClN2O4/c1-4-23(2,22(27)28)30-15-18-13-21(16-9-7-10-19(12-16)29-3)26(25-18)14-17-8-5-6-11-20(17)24/h5-13H,4,14-15H2,1-3H3,(H,27,28)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.60E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345284 (2-[[1-[(2-Bromophenyl)methyl]-5-(3- methoxyphenyl...) Show SMILES COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Br Show InChI InChI=1S/C22H23BrN2O4/c1-22(2,21(26)27)29-14-17-12-20(15-8-6-9-18(11-15)28-3)25(24-17)13-16-7-4-5-10-19(16)23/h4-12H,13-14H2,1-3H3,(H,26,27)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.70E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345280 (2-[[1-[(2-Fluorophenyl)methyl]-5-(3- isobutoxyphe...) Show SMILES CC(C)COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1F Show InChI InChI=1S/C25H29FN2O4/c1-17(2)15-31-21-10-7-9-18(12-21)23-13-20(16-32-25(3,4)24(29)30)27-28(23)14-19-8-5-6-11-22(19)26/h5-13,17H,14-16H2,1-4H3,(H,29,30)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.70E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345316 (2-([1-[(3-methoxyphenyl)methyl]-5-[3-(2- methylpr...) Show SMILES COc1cccc(Cn2nc(COC(C)(C)C(O)=O)cc2-c2cccc(OCC(C)C)c2)c1 Show InChI InChI=1S/C26H32N2O5/c1-18(2)16-32-23-11-7-9-20(13-23)24-14-21(17-33-26(3,4)25(29)30)27-28(24)15-19-8-6-10-22(12-19)31-5/h6-14,18H,15-17H2,1-5H3,(H,29,30)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.70E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345308 (2-({1-[(o-Chlorophenyl)methyl]-5-(m- methoxypheny...) Show SMILES COc1cccc(c1)-c1c(C)c(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl Show InChI InChI=1S/C23H25ClN2O4/c1-15-20(14-30-23(2,3)22(27)28)25-26(13-17-8-5-6-11-19(17)24)21(15)16-9-7-10-18(12-16)29-4/h5-12H,13-14H2,1-4H3,(H,27,28)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.70E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345256 (2-[[5-(4-Chlorophenyl)-1-[(4- chlorophenyl)methyl...) Show SMILES CC(C)(OCc1cc(-c2ccc(Cl)cc2)n(Cc2ccc(Cl)cc2)n1)C(O)=O Show InChI InChI=1S/C21H20Cl2N2O3/c1-21(2,20(26)27)28-13-18-11-19(15-5-9-17(23)10-6-15)25(24-18)12-14-3-7-16(22)8-4-14/h3-11H,12-13H2,1-2H3,(H,26,27)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.90E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345265 (2-[[1-[(2-Chlorophenyl)methyl]-5-(m- tolyl)pyrazo...) Show SMILES Cc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl Show InChI InChI=1S/C22H23ClN2O3/c1-15-7-6-9-16(11-15)20-12-18(14-28-22(2,3)21(26)27)24-25(20)13-17-8-4-5-10-19(17)23/h4-12H,13-14H2,1-3H3,(H,26,27)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.90E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345258 (2-[[1-[(2-Chlorophenyl)methyl]-5-(4- fluorophenyl...) Show SMILES CC(C)(OCc1cc(-c2ccc(F)cc2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C21H20ClFN2O3/c1-21(2,20(26)27)28-13-17-11-19(14-7-9-16(23)10-8-14)25(24-17)12-15-5-3-4-6-18(15)22/h3-11H,12-13H2,1-2H3,(H,26,27)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.30E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345269 (2-[[1-[(2-Chlorophenyl)methyl]-5- cyclohexyl-pyra...) Show SMILES CC(C)(OCc1cc(C2CCCCC2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C21H27ClN2O3/c1-21(2,20(25)26)27-14-17-12-19(15-8-4-3-5-9-15)24(23-17)13-16-10-6-7-11-18(16)22/h6-7,10-12,15H,3-5,8-9,13-14H2,1-2H3,(H,25,26)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.30E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345297 (2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (2,2,2-trifl...) Show SMILES CC(C)(OCc1cc(-c2cccc(OCC(F)(F)F)c2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C23H22ClF3N2O4/c1-22(2,21(30)31)33-13-17-11-20(29(28-17)12-16-6-3-4-9-19(16)24)15-7-5-8-18(10-15)32-14-23(25,26)27/h3-11H,12-14H2,1-2H3,(H,30,31)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.30E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345304 (2-([1-[(o-Chlorophenyl)methyl]-5-[m- (dimethylami...) Show SMILES CN(C)c1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl Show InChI InChI=1S/C23H26ClN3O3/c1-23(2,22(28)29)30-15-18-13-21(16-9-7-10-19(12-16)26(3)4)27(25-18)14-17-8-5-6-11-20(17)24/h5-13H,14-15H2,1-4H3,(H,28,29)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.40E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345330 (US10202350, Example 76 | US10214492, Example 76 | ...) Show SMILES CC(C)(OCc1cc(Oc2ccccc2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C21H21ClN2O4/c1-21(2,20(25)26)27-14-16-12-19(28-17-9-4-3-5-10-17)24(23-16)13-15-8-6-7-11-18(15)22/h3-12H,13-14H2,1-2H3,(H,25,26)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.80E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345263 (2-[[5-(2-Chlorophenyl)-1-[(2- chlorophenyl)methyl...) Show SMILES CC(C)(OCc1cc(-c2ccccc2Cl)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C21H20Cl2N2O3/c1-21(2,20(26)27)28-13-15-11-19(16-8-4-6-10-18(16)23)25(24-15)12-14-7-3-5-9-17(14)22/h3-11H,12-13H2,1-2H3,(H,26,27)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.90E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345285 (2-[[1-[(2-Isopropylphenyl)methyl]-5-(3- methoxyph...) Show SMILES COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1C(C)C Show InChI InChI=1S/C25H30N2O4/c1-17(2)22-12-7-6-9-19(22)15-27-23(18-10-8-11-21(13-18)30-5)14-20(26-27)16-31-25(3,4)24(28)29/h6-14,17H,15-16H2,1-5H3,(H,28,29)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.20E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345314 (US10202350, Example 60 | US10214492, Example 60 | ...) Show SMILES CC(C)COc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1 Show InChI InChI=1S/C25H30N2O4/c1-18(2)16-30-22-12-8-11-20(13-22)23-14-21(17-31-25(3,4)24(28)29)26-27(23)15-19-9-6-5-7-10-19/h5-14,18H,15-17H2,1-4H3,(H,28,29)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.40E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345318 (US10202350, Example 64 | US10214492, Example 64 | ...) Show SMILES COc1ccc(s1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl Show InChI InChI=1S/C20H21ClN2O4S/c1-20(2,19(24)25)27-12-14-10-16(17-8-9-18(26-3)28-17)23(22-14)11-13-6-4-5-7-15(13)21/h4-10H,11-12H2,1-3H3,(H,24,25)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.50E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345320 (2-([1-[(2-chlorophenyl)methyl]-5-(5-methoxythiophe...) Show SMILES COc1cc(cs1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl Show InChI InChI=1S/C20H21ClN2O4S/c1-20(2,19(24)25)27-11-15-9-17(14-8-18(26-3)28-12-14)23(22-15)10-13-6-4-5-7-16(13)21/h4-9,12H,10-11H2,1-3H3,(H,24,25)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.50E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345326 (US10202350, Example 72 | US10214492, Example 72 | ...) Show SMILES CNc1cccc(c1)-c1cc(COC(C)(C)C(O)=O)nn1Cc1ccccc1Cl Show InChI InChI=1S/C22H24ClN3O3/c1-22(2,21(27)28)29-14-18-12-20(15-8-6-9-17(11-15)24-3)26(25-18)13-16-7-4-5-10-19(16)23/h4-12,24H,13-14H2,1-3H3,(H,27,28)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.50E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345272 (2-[[1-[(2-Chlorophenyl)methyl]-5-thiazol- 2-yl-py...) Show SMILES CC(C)(OCc1cc(-c2nccs2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C18H18ClN3O3S/c1-18(2,17(23)24)25-11-13-9-15(16-20-7-8-26-16)22(21-13)10-12-5-3-4-6-14(12)19/h3-9H,10-11H2,1-2H3,(H,23,24)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.50E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345262 (2-[[1-[(2-Chlorophenyl)methyl]-5-phenyl- pyrazol-...) Show SMILES CC(C)(OCc1cc(-c2ccccc2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C21H21ClN2O3/c1-21(2,20(25)26)27-14-17-12-19(15-8-4-3-5-9-15)24(23-17)13-16-10-6-7-11-18(16)22/h3-12H,13-14H2,1-2H3,(H,25,26)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.60E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345300 (2-[[1-[(2-Chlorophenyl)methyl]-5-(3- morpholinoph...) Show SMILES CC(C)(OCc1cc(-c2cccc(c2)N2CCOCC2)n(Cc2ccccc2Cl)n1)C(O)=O Show InChI InChI=1S/C25H28ClN3O4/c1-25(2,24(30)31)33-17-20-15-23(29(27-20)16-19-6-3-4-9-22(19)26)18-7-5-8-21(14-18)28-10-12-32-13-11-28/h3-9,14-15H,10-13,16-17H2,1-2H3,(H,30,31)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.70E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair
Malignant T-cell-amplified sequence 1 (Homo sapiens (human))	BDBM345255 (US10202350, Example 1 | US11724989, Example 1) Show SMILES CC(C)(OCc1cc(-c2ccccc2)n(Cc2cccc(Cl)c2)n1)C(O)=O Show InChI InChI=1S/C21H21ClN2O3/c1-21(2,20(25)26)27-14-18-12-19(16-8-4-3-5-9-16)24(23-18)13-15-7-6-10-17(22)11-15/h3-12H,13-14H2,1-2H3,(H,25,26)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Vettore, LLC US Patent					Assay Description MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...				US Patent US10202350 (2019) BindingDB Entry DOI: 10.7270/Q20K2BPB
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 168 total )  |  Next  |  Last  >>

Jump to: